As we previously discussed here these medications were initially approved by the Food and Drug Administration for the treatment of those with diabetes to help produce insulin and lower blood sugar, but doctors and consumers found that GLP-1s are also effective in weight loss, and many began prescribing them for this purpose
The Architectural Divide: One Molecule or Two
So what explains the difference
Although hair loss is not considered medically serious, the researchers noted that it can affect quality of life, treatment satisfaction and adherence, making it an important consideration as GLP-1 therapies move into long-term use
Without sufficient protein, patients risk losing substantial muscle mass alongside fat tissue, which can reduce metabolic rate, impair physical function, and compromise long-term weight maintenance
Pennington Biomedical Research Center is supported by Nutrition Obesity Research Center (NORC) grant P30 DK072476 titled Nutrition and Metabolic Health Through the Lifespan sponsored by the National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) and by grant U54 GM104940 from the National Institute of General Medical Sciences, which funds the Louisiana Clinical and Translational Science Center
